Kingianic acids A–G, endiandric acid analogues from endiandra kingiana. by Leong, K.H.
  
Molecules 2014, 19, 1732-1747; doi:10.3390/molecules19021732 
 
molecules 
ISSN 1420-3049 
www.mdpi.com/journal/molecules 
Article 
Kingianic Acids A–G, Endiandric Acid Analogues from 
Endiandra kingiana 
Mohamad Nurul Azmi 1,†, Charlotte Gény 2,†, Aurélie Leverrier 2, Marc Litaudon 2,*,  
Vincent Dumontet 2, Nicolas Birlirakis 2, Françoise Guéritte 2, Kok Hoong Leong 3,  
Siti Nadiah Abd. Halim 1, Khalit Mohamad 3 and Khalijah Awang 1,* 
1 Department of Chemistry, Faculty of Science, University Malaya, Kuala Lumpur 50603, Malaysia; 
E-Mails: libra_mine85@yahoo.co.uk (M.N.A.); nadiahhalim@um.edu.my (S.N.A.H.)  
2 Centre de Recherche de Gif, Institut de Chimie des Substances Naturelles (ICSN), CNRS,  
Labex LERMIT, Gif-sur-Yvette Cedex 91198, France; E-Mails: charlotte.geny@cnrs.fr (C.G.); 
aurelie.leverrier@gmail.com (A.L.); vincent.dumontet@cnrs.fr (V.D.);  
nicolas.birlirakis@cnrs.fr (N.B.); francoise.gueritte@wanadoo.fr (F.G.) 
3 Department of Pharmacy, Faculty of Medicine, University Malaya, Kuala Lumpur 50603, 
Malaysia; E-Mails: Leongkh@um.edu.my (K.H.L.); khalitmohamad@um.edu.my (K.M.) 
† These authors contributed equally to this work. Dedicated to the memory of Dr. Khalit Mohamad. 
* Authors to whom correspondence should be addressed; E-Mails: marc.litaudon@cnrs.fr (M.L.); 
khalijah@um.edu.my (K.A.); Tel.: +33-169-82-30-85 (M.L.); Fax: +33-169-07-72-47 (M.L.);  
Tel.: +60-3-7967-4064 (K.A.); Fax: +60-3-7967-4193 (K.A.). 
Received: 14 November 2013; in revised form: 3 January 2014 / Accepted: 23 January 2014 /  
Published: 31 January 2014 
 
Abstract: A phytochemical investigation of the methanolic extract of the bark of 
Endiandra kingiana led to the isolation of seven new tetracyclic endiandric acid analogues, 
kingianic acids A–G (1–7), together with endiandric acid M (8), tsangibeilin B (9) and 
endiandric acid (10). Their structures were determined by 1D- and 2D-NMR analysis in 
combination with HRMS experiments. The structure of compounds 9 and 10 were confirmed 
by single-crystal X-ray diffraction analysis. These compounds were screened for Bcl-xL and 
Mcl-1 binding affinities and cytotoxic activity on various cancer cell lines. Compound 5 
showed moderate cytotoxic activity against human colorectal adeno-carcinoma (HT-29) and 
lung adenocarcinoma epithelial (A549) cell lines, with IC50 values in the range 15–17 µM, and 
compounds 3, 6 and 9 exhibited weak binding affinity for the anti-apoptotic protein Mcl-1. 
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1. Introduction 
In our pursuit to discover bioactive phytochemicals from the Malaysia flora [1–3] we recently 
reported a series of new natural pentacyclic polyketides, named kingianins A-L, isolated from the ethyl 
acetate extract of the bark of Endiandra kingiana Gamble (Lauraceae) [4]. Several kingianins showed 
strong binding affinity to the anti-apoptotic protein Bcl-xL, and can therefore be considered as 
potential anticancer agents [4]. In order to discover additional members of this chemical series or close 
analogues, we have embarked on the investigation on the methanolic extract of the bark of this species. 
E. kingiana is a medium-sized evergreen tree, distributed throughout Peninsular Malaysia and  
Borneo [5–7]. There are about 125 Endiandra species found throughout the tropical regions, including 
10 species in Malaysia [5–7], but to our knowledge only three species: E. introrsa,  
E. anthropophagorum and E. kingiana, have been studied for their phytochemicals. The first one has 
been reported to produce interesting cyclic polyketides, named endiandric acids, possessing eight 
chiral centers, and usually isolated as racemic mixtures [8–11]. It was postulated by Black and  
co-workers that they could be formed by non-enzymatic cyclizations (8ʌe and 6ʌe electrocyclization 
followed by Diels-Alder reaction) of a phenylpolyene acid precursor [12–14]. In 1982, Nicolaou’s 
group successfully synthesized the natural endiandric acids by implementing a biomimetic strategy 
based on Black’s hypothesis [14–17]. Endiandric acids and their close derivatives, beilschmiedic acids, 
are the most characteristic type of natural products isolated from Beilschmiedia and Endiandra species. 
They were found to exhibit various biological activities, such as antibacterial [18–20], antiplasmodial [20], 
antitubercular [21], iNOS inhibitory activity [22], and anticancer properties [20,23]. Recently, 
Williams et al. reported the cytotoxic and antibacterial activities of a series of beilschmiedic acids 
isolated from a Gabonese Beilschmiedia species against NCI-H460 human lung cancer cells and a 
clinical isolate of methicillin-resistant Staphylococcus aureus, respectively [23]. Talonsti et al. have 
also reported recently the isolation of four beilschmiedic acid derivatives, cryptobeilic acids A–D and 
tsangibeilin B from the bark of Endiandra cryptocaryoides [20]. These compounds showed moderate 
antiplasmodial activity against the chloroquinone-resistant Plasmodium falciparum strain NF54, and 
antibacterial activities against Escherichia coli, Acinetobacter calcoaceticus and Pseudomonas  
stutzeri [20].  
The chemical investigation of the methanolic extract of E. kingiana bark extract led to the isolation 
of seven new endiandric acids, kingianic acids A–G (1–7), together with endiandric acid M (8), 
tsangibeilin B (9) and endiandric acid (10) (compound 10 was only found in the “PubChem” database 
(CID 71521970) without an associated reference regarding its origin and its spectroscopic data, so this 
compound is fully described in the present manuscript). Herein, the isolation and structure elucidation 
of the new tetracyclic endiandric acids; kingianic acids A-G, and the cytotoxic activities, Bcl-xL and 
Mcl-1 affinities of compounds 1, 3, 5–9 are reported. 
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2. Results and Discussion 
The EtOAc-soluble part of the E. kingiana methanol extract was subjected to silica gel 
chromatography to afford eight fractions Fr.1-Fr.8. Fractions Fr.4 and Fr.5 were further purified using 
silica gel as well as semi-preparative HPLC leading to the isolation of the kingianic acid series 1–7, 
endiandric acid M (8), tsangibeilin B (9) and endiandric acid 10 (Figure 1). All assignments of 1H- and 
13C-NMR data were then established through in depth analysis of 2D-NMR; NOESY, COSY, HSQC 
and HMBC experiments. All compounds 1–10 were isolated as optically inactive, thus suggesting that 
they are racemic mixtures and their spectroscopic data were very similar. They all possess a 13 carbon 
atom fused rings system and they can be divided into two main skeletal types. Six of compounds (1–5, 
8) belong to the first type as can be seen in endiandric acid K and endiandramide A [22]. While 
compounds 6, 7, 9 and 10 belong to the second type, similar to tsangibeilins A and B and 
endiandramide B [22].  
Figure 1. Structures of compounds 1–10. 
 
Kingianic acid A (1) was isolated as a colorless oil. The HRESIMS spectrum of 1 showed a 
pseudomolecular ion peak [MíH]í at m/z 323.1279 (calcd. 323.1284), consistent with a molecular 
formula C20H20O4 with 11 degrees of unsaturation. Its UV spectrum showed absorption bands at 233 
and 286 nm, suggesting the presence of a benzenoid moiety, and its IR spectrum indicated  
the presence of OH (3,431 cmí1), carbonyl (1,701 cmí1) and methylenedioxy (1,040 and 936 cmí1) 
groups [22]. The 13C-NMR and DEPT spectra exhibited 20 signals, including 13 methines, three 
methylenes, and four quaternary carbons. The resonances of the methines at C-1 (įC 41.8), C-2 (įC 
39.7), C-3 (įC 38.8), C-4 (įC 40.6), C-5 (įC 39.8), C-7 (įC 38.3), C-8 (įC 48.8) and C-9 (įC 34.8), 
including two olefinic carbons at C-10, C-11 and a methylene at C-6 observed in the DEPT spectrum, 
were characteristic of a tetracyclic endiandric acid like endiandric acid K [22]. The 1H and 13C-NMR 
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spectra of 1 (Table 1) were also similar to those of endiandric acid K [22], except for the methylene 
proton signals [įH 2.72 (m, H-1'a); 2.78 (m, H-1'b)]. This group is placed between C-4 of the tetracylic 
acid moiety and C-2' of the benzenoid moiety in 1, instead of three methylenes in endiandric acid K.  
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR data of compounds 1–3 (CDCl3). 
Position 
1 2 3 
įH (J in Hz) įc įH (J in Hz) įc įH (J in Hz) įc 
1 2.71 m 41.8 2.72 dd (1.62, 5.1) 41.8 2.41 m 39.9 
2 2.42 dt (8.5, 5.5) 39.7 2.44 dt (9.3, 3.7) 39.7 2.72 m 41.8 
3 1.73 m 38.8 1.76 m 38.9 1.74 m 38.9 
4 2.00 t (8.5) 40.6 2.07 t (8.0) 40.2 1.85 t (7.5) 39.0 
5 2.34 t (6.5) 39.8 2.37 t (6.0) 39.9 2.38 m 39.8 
6 
1.55 d (13.0)  
1.90 ddd (13.0, 7.5, 5.5) 
38.5 
1.54 d (12.8)  
1.90 ddd (13.0, 7.4, 5.4)
38.4 
1.58 d (12.8)  
1.93 dt (7.1, 12.9)
38.4 
7 2.57 t (5.0) 38.3 2.56 t (4.9) 38.3 2.57 t (5.5) 38.3 
8 2.86 d (3.5) 48.8 2.87 d (2.6) 48.8 2.89 d (3.2) 48.6 
9 2.98 dt (7.0, 4.0) 34.8 2.98 m 34.8 3.05 t (3.6) 34.8 
10 6.22 t (4.0) 131.3 6.22 m 131.3 6.24 t (3.7) 131.9
11 6.22 t (4.0) 132.0 6.22 m 132.0 6.24 t (3.7) 132.3
1' 
2.72 m  
2.78 m 
41.7 
2.83 m  
2.86 m 
41.9 2.35 m 39.3 
2' - 134.7 - 140.9 6.02 dt (6.9, 15.7) 126.9
3' 6.66 s 109.1 7.15 d (7.1) 128.7 6.29 d (15.7) 130.5
4' - 147.5 7.28 t (7.6) 128.3 - 131.4
5' - 145.7 7.19 t (7.3) 125.8 6.90 d (1.2) 108.4
6' 6.72 d (8.0) 108.1 7.28 t (7.6) 128.4 - 148.0
7' 6.60 d (8.0) 121.5 7.15 d (7.1) 128.6 - 146.7
8' 5.92 s 100.8   6.73 d (8.0) 108.2
9'     6.76 d (8.0) 120.3
10'     5.94 s 101.0
C=O - 179.3 - 179.4 - 178.3
The 1H NMR of 1 revealed two cis olefinic proton signals at įH 6.22 (t, J = 4.0 Hz, H-10 and H-11). 
The three aromatic protons resonated as one singlet at įH 6.66 (s, H-3') and two ortho-coupled doublets 
įH 6.72 (d, J = 8.0 Hz, H-6') and 6.60 (d, J = 8.0 Hz, H-7') suggested the presence of a  
1,3,4-trisubstituted aromatic ring. In addition, proton signals at įH 5.92 (s, H-8') confirmed the 
presence of the methylenedioxy group. As determined from the HMBC spectrum, the long-range 
correlations between H-7 (įH 2.57) and H-8 (įH 2.86) to COOH (įC 179.3) indicated the presence of 
carboxylic acid moiety attached to C-8 position of the tetracyclic moiety. Finally, the correlations of 
H-3'/C-1' (įC 41.7), H-7'/C-1', H-1'/C-2' (įC 134.7) and H-5/C-1' determined the connection of the 
methylenedioxyphenyl moiety to the tetracycle core through C-1' (Figure 2). The relative configuration 
of 1 was deduced from NOESY analysis (Figure 3) in combination with biogenetic consideration and 
comparison with endiandric acid K [22]. Based on NOESY spectrum, the Į-orientation of H-9 was 
deduced from the correlations of H-9/H-8 and H-8/H-4. In contrast, other correlations between H-3/H-2, 
H-2/H-1 and H-5/H-6ȕ and H-6 ȕ/H-7 suggested that protons H-1, H-2, H-3, H-5 and H-7 to be  
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ȕ-oriented. Thus, the relative configuration was assigned as rel-(1RS, 2RS, 3RS, 4SR, 5SR, 7SR, 8RS, 
9SR), the same as that of endiandric acid K [22].  
Figure 2. Key 1H-1HCOSY (bold) and HMBC (1Hĺ13C) correlations of 1, 6 and 10. 
 
Figure 3. Selected NOESY (1Hļ1H) correlations of 1, 6 and 10. 
 
Kingianic acid B (2) was obtained as a yellowish oil. The HRESIMS of 2 showed a 
pseudomolecular ion peak [MíH]í at m/z 279.1398 (calcd. 279.1385) which indicated the molecular 
formula C19H20O2, and was consistent with 10 degrees of unsaturation. The UV, IR, 1H and 13C-NMR 
data (Table 1) were similar to those of 1. The 13C-NMR and DEPT spectra exhibited 11 signals for an 
endiandric acid moiety, including the presence of 10 methines and one methylene group. The NMR 
HO O
8
9
7
6
5
4
3 13
2 1
12
11
10
1'
8
O
HO
1
2
3
9
10
11
8
7
6 5
4
1'
2'
7'
6'
3'
4'
5'
O
O
8'
O
O
HO O
14
6
5
4
3
2
1
11
1213
7
8
9
10
1'
2'
7'
6'
3'
5'
4'
8'
1
6 10
4'
3'
2'
5'
6'
7'
H
H
H
H
H
H
HO O
14
6
5
4
3
2 1 11
1213
7
8
9
10
1'
2'
7'
6'
3'
5'
4'
H
H H
6
O
HO
O
OH
H
H
H
H
1
2
39
10
11
8
7
6 5
4
1'
2'
7'
6'
3'
4'
5'
8'
1
H
H
H
H
H
O
O
H
H
H
HH
H
HO O
14
6
5
4
3
2 1
11
1213
7
8
9
10
1'
2'
7'
6'
3'
5'
4'
8'H
H
H H
H
10
Molecules 2014, 19 1737 
 
 
data of compound 2 were nearly identical to those of 1, except for the substituent at C-4, indicating 
that the methylenedioxyphenyl in 1 was replaced by a monosubstituted phenyl moiety in 2 [įH 7.15  
(d, J = 7.1 Hz, H-3' and H-7'); 7.28 (t, J = 7.6 Hz, H-4' and H-6') and 7.19 (t, J = 7.3 Hz, H-5')]. 
Analysis of the NOESY spectrum indicated that 2 possess the same relative configuration as 1. 
Kingianic acids C (3) and D (4) were isolated as yellowish oils. The molecular formula of 3 
(C22H22O4) and 4 (C21H22O2) were established by the [MíH]í ion peaks at m/z 349.1439 (calcd. 
349.1440) and 305.1539 (calcd. 305.1542) in the HRESIMS, respectively. The 1H and 13C-NMR data 
(Tables 1 and 2) of compounds 3 and 4 were very similar to both 1 and 2, and the analysis of the 
COSY correlations of 3 and 4 revealed the characteristic signals for a tetra-fused ring system as seen in 
compounds 1 and 2. The presence of a carbonyl group was indicated by the absorption band at 1,697 cmí1 
in the IR spectrum of 3 and 1,693 cmí1 for 4, and confirmed by signals at įC 178.3 and 177.5 in their 
13C-NMR spectra, respectively. In the HMBC spectra of 3 and 4, the correlations from H-8 and H-7 to 
COOH confirmed the connectivity of the carboxylic acid function. Besides the characteristic 
tetracyclic moiety, analysis of COSY and HMBC correlations indicated that the methylenedioxyphenyl 
and monosubstituted phenyl moieties were attached at C-4 in compounds 3 and 4, respectively. The 
geometry of C-2', 3' double bond was assigned as trans on the basis of the coupling constants of H-3' 
(įH 6.29, d, J = 15.7 Hz) and (įH 6.38, d, J = 15.8 Hz) in both compounds (Tables 1 and 2). The 
NOESY spectra of 3 and 4, showed correlation between H-8 and H-4 indicating that the benzyl moiety 
at C-4 assumed a ȕ-position on the tetracyclic framework. Thus, the relative configuration of 3 and 4 
were determined to be rel-(1RS, 2RS, 3RS, 4SR, 5SR, 7SR, 8RS, 9SR), the same as in compounds 1 and 2.  
Kingianic acid E (5) was isolated as a yellowish oil. HRESIMS of 5 gave an [MíH]- ion at m/z 
323.1298 (calcd 323.1284), consistent with a molecular formula of C20H20O4 with 11 degrees of 
unsaturation. Its UV and IR spectra were similar to those of 1. A close examination of the NMR 
spectra of compound 5 (Table 2) indicated that 5 possessed the same tetracyclic moiety as 1, but with 
different substituents at C-4 and C-8. The two substituents consisted of an acetic acid group [įH 2.64 
(m, H2-1'); įC 176.9 (COOH)] and a methylenedioxyphenyl moiety (įH 6.61, s, H-13; 6.67, d, J = 8.0 
Hz, H-16; 6.54, d, J = 8.0 Hz, H-17; and 5.89, s, H-18). Their location at C-4 and C-8, respectively, 
was deduced from COSY and HMBC correlations. The COSY correlation between H-4 and H2-1' on 
one hand, and HMBC correlations from H-8 (įH 3.25) to C-12 (įC 140.2), and from H-13 (įH 6.61)/H-17 
(įH 6.54) to C-8 (įC 47.9) on the other hand, confirmed the location of the acetic acid group and the 
methylenedioxyphenyl moiety at C-4 and C-8, respectively. The relative configuration of compound 5, 
named kingianic acid E, was fixed by a NOESY experiment as the same as that of compound 1. 
The molecular formula C21H22O2 of kingianic acid F (6) was determined by HRESIMS analysis; 
305.1557 (calcd 305.1542), for which 10 degrees of unsaturation could be deduced. The UV spectrum 
of 6 showed characteristic absorption bands at 232 and 288 nm suggesting the presence of a benzenoid 
moiety, and its IR spectrum showed absorption bands at 3,432 cmí1 for an OH group and 1,696 cmí1 for a 
carbonyl group. The 13C-NMR and DEPT spectrum, which showed 21 signals for two methylenes, 16 
methines (nine olefinic), and two quaternary and a carbonyl carbon that were characteristic of the 
tetracyclic endiandric acid skeleton as seen in tsangibeilin B (9) [22]. The 1H and 13C-NMR spectra of 
compound 6 were reminiscent to those of 9, except for the absence of signal for a methylenedioxy 
group in 6 and the appearance of five aromatic proton and carbon signals, thus suggesting that the 
methylenedioxyphenyl moiety was replaced by a monosubstituted phenyl moiety. All carbon-carbon 
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connectivities of compound 6 were determined through a thorough analysis of 2D NMR spectra 
(Figures 2 and 3), and comparison with those of tsangibeilin B (9). The location of the COOH group at 
C-6, and the phenyl moiety at C-11, was confirmed by HMBC correlation from H-6 to the carbonyl 
carbon at įC 179.4, and from COSY correlations between H-11 and H2-1', respectively. The relative 
configuration of 6 was ascertained by the careful inspection of NOESY spectrum (Figure 3) and 
biogenesis considerations of tsangibeilin B as reference [22].  
Table 2. 1H (600 MHz) and 13C (150 MHz) NMR data of compounds 4 and 5 (CDCl3). 
Position 
4 5 
įH (J in Hz) įc įH (J in Hz) įc 
1 2.73 m 41.9 2.76 dd (5.1, 10.8) 42.4 
2 2.40 m 39.8 2.46 m 39.9 
3 1.76 m 39.0 2.62 m 40.3 
4 1.88 t (7.4) 38.9 2.44 m 35.3 
5 2.36 t (7.4) 39.9 2.37 t (6.6) 40.2 
6 
1.61 d (12.7) 
1.93 m 
38.4 
1.74 d (12.6)  
1.94 m 
39.3 
7 2.58 t (5.1) 38.3 2.31 t (4.6) 43.1 
8 2.90 d (3.8) 48.6 3.25 d (2.5) 47.9 
9 3.06 t (3.8) 34.8 2.72 m 39.6 
10 6.23 d (3.1) 131.4 5.93 t (7.0) 132.3 
11 6.24 d (3.0) 131.9 6.29 t (7.3) 130.5 
12    140.2 
13   6.61 s 109.5 
14    146.9 
15    145.2 
16   6.67 d (8.0) 107.4 
17   6.54 d (8.0) 121.6 
18   5.89 s 100.7 
1' 2.43 m 39.4 2.64 m 40.4 
2' 6.19 m 128.7   
3' 6.38 d (15.8) 131.0   
4' - 137.7   
5' 7.35 d (7.2) 126.0   
6' 7.30 t (7.6) 128.5   
7' 7.20 t (7.3) 127.0   
8' 7.30 t (7.6) 128.5   
9' 7.35 d (7.2) 126.0   
10'     
C=O - 177.5  176.9 
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Thus, the relative configuration of 6, named kingianic acid F or 11{1'-[phenyl]}-
tetracyclo[5.4.2.03,13.010,12]trideca-4,8-dien-6-carboxylic acid (kingianic acid F), was assigned as rel-
(1RS, 2RS, 3RS, 4SR, 5SR, 7SR, 8RS, 9SR), same as that of tsangibeilin B (9) [22]. 
Kingianic acid G (7) was obtained as a yellowish oil. The negative-mode HREIMS exhibited a  
quasi-molecular ion peak at m/z 365.1401 [MíH]í (calcd. 365.1389), which suggested the molecular 
formula of C22H22O5, and implied 12 degrees of unsaturation. The UV absorption bands at Ȝmax 234 
and 286 nm confirmed the presence of a benzenoid nucleus [23]. The absorption bands at 2,600–3,300, 
1,687, 1,632, 1,040 and 937 cmí1 in the IR spectrum revealed the presence of OH, C=O, C=C and  
O-CH2-O groups, respectively. The 1H and 13C-NMR data of 7 were similar to those of 10, suggesting 
that they both share a common tetracyclic endiandric acid skeleton, except for the presence of an Į-OH 
at įH 4.23 (d, J = 9.8 Hz, H-4) in 7. The location of this hydroxy group at C-4 was deduced from the 
COSY correlations between H-3/H-5 and H-4, and HMBC correlations from H-2a (įH 1.29), H-3 and 
H-13 to C-4. The relative configuration of the stereogenic centers was established by biogenetic 
considerations [24], analysis of the NOESY spectrum and comparison with NMR data reported in the 
literature [23]. NOESY correlations between H-12 and H-1/H-10/H-13, H-1, and between H-7 and H-
8/H-13 confirmed that protons H-1, H-7, H-10, H-12 and H-13 are all cofacial, arbitrarily assigned as 
ȕ-oriented. Since cross peaks between H-4 at įH 4.23 and H-2a and H-2b, at įH 1.29 and 1.79 
respectively, were equally intense, the relative configuration at C-4 could not be deduced from the 
NOESY spectrum. However, comparison of NMR data of kingianic acid G (7) with data reported in 
the literature for beilschmiedic acids H and I allowed the assignment of the 4-OH configuration [23]. 
Indeed, since compound 7 possesses similar 13C chemical shifts to beilschmiedic acid H for carbons  
C-3, C-4 and C-5 (įC 44.1, 73.6, 145.6, respectively for 7; įC 45.1, 74.5 and 145.8, respectively for 
beilschmiedic acid H), it can be deduced that the hydroxy group is D-oriented, as was the case for 
beilschmiedic acid H [23]. In the case of beilschmiedic acid I, having a ȕ-oriented hydroxy group at  
C-4, chemical shifts of C-3, C-4 and C-5 are more shielded; 43.1, 65.9 and 141.5 ppm, respectively [23]. 
Thus, kingianic acid G (7) was proposed to have the same relative configuration as beilschmiedic acid H. 
Compound 10 was obtained as an amorphous solid. The HRESIMS spectrum of 10 showed a 
pseudomolecular ion peak [MíH]í at m/z 349.1431(calcd. 349.1440), consistent with a molecular 
formula of C22H22O4, with 12 degrees of unsaturation. Its IR spectrum showed strong absorption bands 
at 1,685 cmí1 for C=O, and 1,630 cmí1 for C=C, and UV absorption bands at Ȝmax 234 and 286 nm 
suggesting the presence of a benzenoid moiety. The 13C-NMR spectrum of 10 (Table 3) contained  
22 carbons signals, which were sorted by DEPT-135 NMR and HSQC into 5 quaternary carbons,  
14 methines and 4 methylene groups. Resonances of methines at įC 40.9 (C-1), 35.6 (C-3), 144.6 (C-5), 
33.3 (C-7), 127.1 (C-8), 127.0 (C-9), 33.2 (C-10), 46.9 (C-11), 34.0 (C-12) and 42.2 (C-13), and 
methylene groups at įC 37.0 (C-2) and 32.2 (C-4) observed in the DEPT spectrum, were characteristic 
of a tetracyclic endiandric acid skeleton as seen in cryptobeilic acids A-D [20]. The 13C-NMR 
spectrum showed also signals of a conjugated carbonyl group at įC 178.0 (COOH), an olefinic 
quaternary carbon at įC 134.6 (C-6) and carbons of a substituted methylenedioxybenzyl moiety  
(C-1'-C-8'). The presence of olefinic methines in 10 was confirmed by the 1H-NMR spectrum (Table 3), 
which showed a broad singlet of proton H-5 at įH 7.23 (brs, H-5) and a pair of protons appearing as 
doublet at įH 5.39 (d, J = 10.0 Hz, H-8) and 5.54 (d, J = 10.0 Hz, H-9). The ortho coupled proton H-6' 
and H-7' resonated as a pair of doublets at įH 6.71 (d, J = 7.9 Hz, H-6') and 6.60 (d, J = 7.9 Hz, H-7'), 
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while H-3' appeared as a singlet at įH 6.65 (s, H-3'). In addition, protons signal at įH 5.91 (s, H-8') 
confirmed the presence of the methylenedioxy group. HMBC correlations (Figure 2) from H-5 to C-6 
(įC 134.6) and COOH (įC 178.0), and from H-8 to C-6 established the location of the carboxylic group 
at C-6. The attachment of the methylenedioxybenzyl moiety at H-11 was confirmed by the correlation 
from H-11 to C-2', and from H-1' to C-10 and C-1. The relative configuration of the asymmetric 
carbons was established by NOESY analysis (Figure 3) and confirmed by X-ray crystallographic 
analysis (see Supporting Information). Therefore, the relative configuration of H-1, H-3, H-6, H-7,  
H-10, H-11, H-12, and H-13 was assigned as rel-(1SR,3RS,7RS,10RS,11SR,12SR,13SR), same as that 
of beilschmiedic acid H [23].  
Table 3. 1H (600 MHz) and 13C (150 MHz) NMR data of compounds 6, 7, and 10 (CDCl3). 
Position 
6 7 10 
įH (J in Hz) įc įH (J in Hz) įc įH (J in Hz) įc 
1 2.45 m 41.0 2.48 m 40.9 2.42 m 40.9 
2 1.30 dt (6.3, 12.1)  1.53 dd (6.4, 11.9) 34.7 
1.29 m  
1.79 m 35.0 
1.20 m  
1.53 m 37.0 
3 2.55 m 36.9 2.08 m 44.1 2.04 m 35.6 
4 6.19 d (9.7) 134.4 4.23 d (9.8) 73.6 2.08 m, 2.47 m 32.2 
5 5.72 d (9.6) 123.9 7.03 brs 145.6 7.23 brs 144.6 
6 3.00 m 49.0 - 134.3 - 134.6 
7 2.84 m 32.8 3.23 brs 33.2 3.26 brs 33.3 
8 5.40 m 129.8 5.43 d (10.5) 127.7 5.39 d (10.0) 127.1 
9 5.42 m 129.1 5.53 d (10.5) 126.2 5.54 d (10.0) 127.0 
10 2.39 m 34.5 2.42 m 33.7 2.40 m 33.2 
11 1.82 m 46.9 1.76 m 46.8 1.74 m 46.9 
12 2.70 dd (7.7, 16.2) 32.9 2.80 m 33.6 2.77 m 34.0 
13 1.73 m 42.0 1.86 m 40.8 1.68 m 42.2 
1' 2.81 m 42.9 2.71 d (8.0) 42.5 2.70 d (8.0) 42.6 
2' - 140.7 - 134.6 - 134.6 
3' 7.15 d (6.8) 128.6 6.64 s 108.9 6.65 s 109.0 
4' 7.24 t (6.7) 128.4 - 147.5 - 147.4 
5' 6.20 dt (2.1, 7.3) 125.8 - 145.6 - 145.6 
6' 7.24 t (6.7) 128.4 6.71 d (7.9) 108.1 6.71 d (7.9) 108.0 
7' 7.15 d (6.8) 128.6 6.59 d (7.9) 121.3 6.60 d (7.9) 121.3 
8'   5.91 s 100.7 5.91 s 100.7 
C=O  179.4  170.3  178.0 
Endiandric acid M (8) and tsangibeilin B (9) were readily identified by comparison with literature 
data [22,25]. The structure and relative configuration of tsangibeilin B (9) were confirmed by  
single-crystal X-ray analysis (see Supporting Information). 
Compounds 1, 3, 5–9 were screened against the anti-apoptotic proteins Bcl-xL and Mcl-1 using 
fluorescence polarization assays according to Qian and co-workers [26]. Assays are based on the 
interaction of fluorescein-labeled peptides [the BH3 domain of BAK protein (F-Bak) or BID protein 
(F-Bid) to Bcl-xL and Mcl-1, respectively]. No binding was detected for Bcl-xL and only weak 
binding affinity for Mcl-1 (25%–30% inhibition at 20 µM and  75% at 100 µM) were obtained with 
compounds 3, 6 and 9 (Table 4). In these assays, amount of compounds 2, 4 and 10 were not sufficient 
for this biological evaluation.  
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Table 4. Biological activities of compounds 1, 3, 5–9. 
Compounds 
Bcl-xL/Bak binding affinity 
(%) 
Mcl-1/Bid binding affinity 
(%) 
Cytotoxicity  
(IC50 in µM,mean ± s.d., n = 3) 
20 ȝM 100 ȝM 20 ȝM 100 ȝM HT-29 A549 PC3 
1 3 ± 1.5 21 ± 1.8 3 ± 2.0 36 ± 2.3 35.0 ± 0.2 85.4 ± 0.2 >100 
3 9 ± 1.5 25 ± 1.7 30 ± 2.2 75 ± 1.1 >100 85.3 ± 0.2 >100 
5 2 ± 1.4 1 ± 0.8 3 ± 1.3 8 ± 5.5 17.1 ± 0.1 15.4 ± 0.2 77.2 ± 0.2 
6 4 ± 1.6 22 ± 2.9 28 ± 3.7 80 ± 0.7 NT NT NT 
7 5 ± 1.3 19 ± 1.6 8 ± 1.1 47 ± 2.9 NT NT NT 
8 0 10 ± 0.5 4 ± 0.8 39 ± 0.9 >100 >100 >100 
9 6 ± 1.5 26 ± 2.5 25 ± 2.1 81 ± 2.4 >100 38.1 ± 0.1 >100 
U-Bak (Ki)  12 ± 1 nM      
U-Bid (Ki)    16 ± 2 nM    
ABT-737 (Ki)  57 ± 10 nM  47 ± 22 nM    
Cisplatin     70.3 ± 1.1 36.2 ± 1.4 44.5 ± 7.7 
NT: not tested; U-Bak and U-bid correspond to unlabeled peptides Bak and Bid, respectively. 
Compounds 1, 3, 5, 8 and 9 were screened for cytotoxic activity against A549  
(lung adenocarcinoma epithelial), HT29 (colorectal adenocarcinoma) and PC3 (prostate 
adenocarcinoma) cell lines using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt (MTS)-based assay (Table 4). Compound 5 showed moderate 
cytotoxic activity against lung adenocarcinoma epithelial (A549) and colorectal adenocarcinoma cell 
lines (HT-29) with IC50 of 15.36 ± 0.19 µM and 17.10 ± 0.11 µM, respectively. The other compounds 
showed very weak or devoid of (A549) cytotoxic activity against the cancer cell lines tested. Our 
results are in agreement with a previous study by Williams, in which some synthetic tetracyclic 
endiandric acids were not active on prostate adenocarcinoma cancer cells (PC3), but significantly 
active on lung carcinoma cells [23]. 
3. Experimental  
3.1. General 
Optical rotations were measured on a JASCO P-1020 polarimeter. IR spectra (neat) were taken on a 
Perkin Elmer RX1 FT-IR spectrometer. 1D (1H, 13C, DEPT) and 2D (COSY, NOESY, HSQC, HMBC) 
NMR experiments were carried out on a Bruker Avance 600 (600 MHz for 1H NMR, 150 MHz for 13C 
NMR) spectrometer. Data were analysed via TopSpin software package. Chemical shifts were 
internally referenced to the solvent signals in CDCl3 (1H, į 7.26; 13C, į 77.0). High-resolution ESIMS 
on a Thermoquest TLM LCQ Deca ion-trap mass spectrometer. Silica gels (230–400 mesh) (Merck) 
were used for column chromatography (CC), and silica gel 60 F-254 (Merck) was used for analytical 
TLC. Agilent® Eclipse Zorbax C18 column (250 × 9.4 mm, 3.5 µm) and Waters® X-Bridge C18 
column (250 × 10.0 mm, 5.0 µm); were used for semi-preparative HPLC separations using a Waters 
auto purification system equipped with a sample manager (Waters 2767), a column fluidics organizer, 
a binary pump (Waters 2525), a UV–Vis diode array detector (190–600 nm, Waters 2996), and a  
PL-ELS 1000 ELSD Polymer Laboratory detector. X-ray data collection was obtained from a 
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BrukerAPEX2; cell refinement: SMART [27]; data reduction: SAINT [27]; program(s) used to solve 
the structure: SHELXTL [28]; program(s) used to refine structure: SHELXTL [28]. 
3.2. Plant Material 
The bark of Endiandra kingiana Gamble was collected at Reserved Forest Sg. Temau, Kuala Lipis, 
Pahang, Malaysia in May 2006. This plant was identified by T. Leong Eng Botanist University of 
Malaya. A voucher specimen (KL-5243) has been deposited at the Herbarium of the Department of 
Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia. 
3.3. Extraction and Isolation 
The air-dried bark of E. kingiana (1.5 kg) were sliced, ground and extracted with EtOAc (3 × 1.5 L) 
followed by MeOH (3 × 1.5 L) at 40 °C and 100 bar using a Zippertex static high-pressure, high-
temperature extractor developed at the ICSN pilot unit. The methanol extract was concentrated under 
reduced pressure and was partitioned with EtOAc/H2O (1:1, v/v) to afford an EtOAc-soluble fraction 
(22.5 g) and a H2O-soluble fraction (91.7 g). The EtOAc-soluble fraction (22 g) was subjected to  
column chromatography (CC, 660 g SiO2, 230–400 mesh; hexane/dichloromethane/methanol step 
gradient) to give eight fractions, identified as Fr. 1–Fr. 8. 
Fr. 4 (4.3 g) was subjected to CC (129 g, SiO2, 230–400 mesh; hexane/AcOEt step gradient) to 
obtain 20 subfractions base on TLC profile: Fr. 4.1–Fr. 4.20. Fraction Fr. 4.3 (37.8 mg) was separated 
using semi-preparative C18 HPLC eluted at 3.5 mL/min isocratically with MeCN-H2O 65:35 + 0.1% 
formic acid from 5 to 50 min (Agilent® Eclipse Zorbax C18 column (250 × 9.4 mm, 3.5 µm). Serial 
collections afforded 2 (tR 8.0 min, 1.2 mg) and 4 (tR 16.0 min, 1.0 mg). 1 (tR 13.1 min, 12.1 mg),  
6 (tR 24.8 min, 3.4 mg) and 10 (tR 19.9 min, 1.2 mg) were purified from the fraction Fr. 4.4 (71.0 mg) 
with a semi-preparative C-18 column (Agilent® Eclipse Zorbax C18 column (250 × 9.4 mm, 3.5 µm) 
using MeCN-H2O 65:35 plus 0.1% formic acid at 3.5 mL/min. Further analogues were separated from 
fraction Fr. 4.7 (41.4 mg) and separated using semi-preparative C-18 column (Agilent® Eclipse Zorbax 
C18 column (250 × 9.4 mm, 3.5 µm) using MeCN-H2O 65:35 plus 0.1% formic acid at 3.5 mL/min. 
Serial collections afforded 9 (tR 14.7 min, 1.8 mg) and 3 (tR 16.4 min, 4.4 mg). From fraction Fr 4.14 
(72.4 mg), 5 (tR 14.6 min, 1.4 mg) and 8 (tR 25.1 min, 2.0 mg) were isolated using semi-preparative 
HPLC eluted at 3.5 mL/min isocratically with MeCN-H2O 60:40 plus 0.1% formic acid (Agilent® 
Eclipse Zorbax C18 column (250 × 9.4 mm, 3.5 µm). Fr. 5 (0.7 g) was subjected to CC (21 g, SiO2, 
230–400 mesh; hexane/AcOEt step gradient) to obtain 12 subfractions according to their TLC profiles. 
Fraction Fr. 5.7 (26.8 mg) was purified using a semi-preparative C18 column (Waters® X-Bridge C18 
column (250 × 10.0 mm, 5.0 µm) using MeCN-H2O 50:50 plus 0.1% formic acid at 3.0 mL/min 
afforded 7 (tR 13.4 min, 1.5 mg).  
3.4. Spectral Data 
Kingianic acid A (1): yellowish oil; >D@25 D  ± 0 (c 0.20, CHCl3); UV (MeOH) Ȝmax 233, 286 nm;  
IR (neat) Ȟmax 3431(OH), 1701 (C=O), 1040, 936 (OCH2O) cmí1; 1H-NMR and 13C-NMR, see Table 1; 
HRESIMS m/z 323.1279 [MíH]í (calcd for C20H19O4, 323.1284). 
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Kingianic acid B (2): yellowish oil; >D@25 D  ± 0 (c 0.12, CHCl3); UV (MeOH) Ȝmax 212, 287 nm;  
IR (neat) Ȟmax 3432(OH), 1721 (C=O) cmí1; 1H-NMR and 13C-NMR, see Table 1; HRESIMS m/z 
279.1398 [MíH]í (calcd for C19H19O2, 279.1385). 
Kingianic acid C (3): yellowish oil; >D@25 D  ± 0 (c 0.20, CHCl3); UV (MeOH) Ȝmax 212, 290 nm;  
IR (neat) Ȟmax 3437 (OH), 1697 (C=O), 1037, 923 (OCH2O) cmí1; 1H-NMR and 13C-NMR, see Table 1; 
HRESIMS m/z 349.1439 [MíH]í (calcd for C22H21O4, 349.1440). 
Kingianic acid D (4): yellowish oil; >D@25 D  ± 0 (c 0.10, CHCl3); UV (MeOH) Ȝmax 212, 289 nm;  
IR (neat) Ȟmax 3440(OH), 1693 (C=O) cmí1; 1H-NMR and 13C-NMR, see Table 2; HRESIMS m/z 
305.1539 [MíH]í (calcd for C21H21O2, 305.1542). 
Kingianic acid E (5): yellowish oil; >D@25 D  ± 0 (c 0.14, CHCl3); UV (MeOH) Ȝmax 234, 286 nm;  
IR (neat) Ȟmax 3444(OH), 1665 (C=O), 1039, 938 (OCH2O) cmí1; 1H-NMR and 13C-NMR, see Table 2; 
HRESIMS m/z 323.1298 [MíH]í (calcd for C20H19O4, 323.1284). 
Kingianic acid F (6): yellowish oil; >D@25 D  ± 0 (c 0.16, CHCl3); UV (MeOH) Ȝmax 232, 288 nm;  
IR (neat) Ȟmax 3432 (OH), 1696 (C=O) cmí1; 1H-NMR and 13C-NMR, see Table 3; HRESIMS m/z 
305.1557 [MíH]í (calcd for C21H21O2, 305.1542). 
Kingianic acid G (7). Yellowish oil. >D@25 D  ± 0 (c 0.14, CHCl3). UV (MeOH) Ȝmax 234, 286 nm.  
IR (neat) Ȟmax 2600–3300 (OH), 1687 (C=O), 1632 (C=C) and 1040, 937 (OCH2O) cmí1. 1H-NMR and 
13C-NMR, see Table 3. HREIMS: m/z 365.1401 [MíH]í (calcd for C22H21O5, 365.1389).  
Compound 10: Amorphous solid. >D@ 25 D  ± 0 (c 0.12, CHCl3). UV (MeOH) Ȝmax 234, 286 nm.  
IR (neat) Ȟmax 1685 (C=O), 1630 (C=C) and 1039, 935 (OCH2O) cmí1. 1H-NMR and 13C-NMR,  
see Table 3. HREIMS: m/z 349.1431[MíH]í (calcd for C22H21O4, 349.1440). A colourless crystal was 
obtained from MeOH, crystallized in the monoclinic crystal system with P21/c space group. Cell 
parameters: a = 6.141(2)Å; b = 23.448(8) Å; c = 12.366(4) Å; ȕ = 104.38˚; V = 1834.58(8) Å3, T 100 
K. For the X-ray crystallographic data of compound 10 see Supporting Information. Supplementary 
crystallographic data have been deposited with the CCDC as CCDC-918161.  
CCDC-918161 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 
Union Road, Cambridge CB2 1EZ, UK; Fax: +44 1223 336033; E-mail: deposit@ccdc.cam.ac.uk). 
3.5. Bcl-xL and Mcl-1 Binding Affinity Assays 
The binding affinities of compounds for Bcl-xL and Mcl-1 were evaluated by competition against 
fluorescently labelled reference compounds, Bak and Bid, respectively, as described by Qian et al. [26]. 
Human 45ǂ -84/ C37 ǂ Bcl-xL and mouse DN150/DC25 Mcl-1 proteins were recombinantly produced 
by N. Birlirakis at ICSN. Bak, 5-Carboxyfluorescein-Bak, Bid and 5-carboxyfluorescein-Bid peptides 
were synthetized by PolyPeptide Laboratories (Strasbourg, France). All sequences are available in the 
Supporting Information (S37). Unlabeled peptides were dissolved in DMSO (Carlo Erba, Val de Reuil, 
France) and labelled peptides were diluted in assay buffer, which contained 20 mM Na2HPO4 (pH 7.4), 
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50 mM NaCl, 2 µM EDTA, 0.05% Pluronic F-68, without pluronic acid for storage at í20 °C. Liquid 
handling instrument, Biomek®NX and Biomeck®3000 (Beckman Coulter, Villepinte, France), were 
used to add protein and fluorescein-labelled peptides. 15 nM labelled BH3 peptide, 100 nM protein, 
and 100 ȝM of unlabelled BH3 peptide or compound (first diluted in 10 mM DMSO and then buffer 
for final concentration from 10í9 to 10í4 M) into a final volume of 40 µL were distributed in a 96 well 
black polystyrene flat-bottomed microplate (VWR 734-1622). The microplate was then incubated at 
room temperature for 1 h and shaken before fluorescent polarization measure. Fluorescence 
polarization in millipolarization units was measured with a Beckman Coulter Paradigm® using FP 
cartridge (Ȝex 485 nm, Ȝem 535nm). The exposure time was 300 ms per channel. All experimental data 
were collected using the Biomek Software® (Beckman Coulter, Inc, Brea, CA, USA) and analysed 
using Microsoft Excel 2010 (Microsoft, Redmond, WA, USA). Results are expressed as binding 
activity, i.e., percentage of inhibition of the binding of labelled reference compound, or as Ki, the 
concentration corresponding to 50% of such inhibition, and corrected for experimental conditions 
according to Kenakin rearranged equation [29], which is adapted from Cheng and Prusoff equation [30]. 
ABT-737, which was kindly provided by O. Nosjean (Institut de Recherche Servier, Croissy, France), 
and unlabeled peptides Bak and Bid were used as positives control. The performance of the assays was 
monitored by use of Z' factors as described by Zhang et al. [31]. The Z' factors for these assays are 0.8 
(Bcl-xL/Bak) and 0.7 (Mcl-1/Bid) indicating that they should be robust assays.  
3.6. Cell Viability Assay 
Human cancer cell lines A549 (Lung adenocarcinoma epithelial), HT29 (Colorectal adenocarcinoma) 
and PC3 (Prostate adenocarcinoma) cells were obtained from the ATCC (Manassas, VA, USA). Cells 
were grown in RPMI-1640 or DMEM medium with 10% FBS supplemented with 4 mM  
L-glutamine and 1% penicillin-streptomycin. For experimental purposes, the cells growing 
exponentially and maintained at 70%–80% confluency were used. Cells were seeded into 96-well 
plates at 104 cells/well and allowed to adhere overnight; the medium was then removed. A stock 
solution of test compound in DMSO was diluted in medium to generate a series of working solutions. 
Aliquots (100 ȝL) of the working solutions were added to the appropriate test wells to expose cells to 
the final concentrations of compound in a total volume of 100 ȝL. Nine different concentrations  
(100 µL–0.4 µL) were tested, in triplicates. Cisplatin is used as a positive control and wells containing 
vehicle without compound were used as negative controls. Plates were kept for 48 h in a 37 °C, 5% 
CO2 incubator. After incubation, viable cells were detected with the CellTiter 96 AQueous cell 
proliferation assay (Promega Corp., Madison, WI, USA). Plates were read in a microplate reader 
(Tecan Infinite® 200 PRO series, Mannedorf, Switzerland) at 490nm. Then, dose-response curves were 
generated and the IC50 values were determined using GraphPad Prism 5.04 software (La Jolla, CA, 
USA [32]. 
4. Conclusions  
The phytochemical investigation of Endiandra kingiana methanolic bark extract has led to the 
isolation of seven new tetracyclic endiandric acid analogues, named kingianic acids A–G (1–7), 
together with endiandric acid M (8), tsangibeilin B (9) and compound 10. These compounds were 
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screened for Bcl-xL and Mcl-1 binding affinities, and cytotoxic activity on various cancer cell lines. 
Compound 5 showed moderate cytotoxic activity, with IC50 values in the range 15–17 µM, and 
compounds 3, 6 and 9 exhibited weak binding affinity for the anti-apoptotic protein Mcl-1. This is the 
first report of binding affinity toward Mcl-1 for endiandric acid analogues. 
Supplementary Materials 
Supplementary materials: HRESIMS and NMR spectra for compounds 1–7 and 10, and the X-ray 
crystallographic analysis data of tsangibeilin B (9) and endiandric acid 10 can be accessed at: 
http://www.mdpi.com/1420-3049/19/2/1732/s1. 
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